Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Best functional limits – it’s a ripe controversy in NATO SC, with a variety of AFFs and coherent NEG ground

Melson 3 Ashley R. Melson, JD, RPT, “Bioterrorism, Biodefense, and Biotechnology in the Military: A Comparative Analysis of Legal and Ethical Issues in the Research, Development, and Use of Biotechnological Products on American and British Soldiers,” 2003, https://law.bepress.com/cgi/viewcontent.cgi?article=1117&context=expresso /GoGreen!

Also affected on a global scale and, perhaps, ever-so-evident with the recent threats of bioterrorism, are the opportunities biotechnology presents in the military context,20 which is defined as “the exploitation and manipulation of biological systems to benefit overall military capability”21. According to a recent report by the Information Assurance Technology Analysis Center (IATAC), “history has shown that an infusion of technology can provide a significant military advantage to the side that first realizes its potential and exploits it.”22 However, the historical examples described, namely invention of the tank, development of U.S. naval aviation capabilities, and technologies emerging from the Information Revolution, fail to invoke the legal and ethical complexities presented by biotechnological research, development, and use in the military. Such concerns become particularly relevant in light of the history of abuse of civilians and service member subjects in research conducted or sponsored by the militaries of both the U.S.23 and its European Ally, the United Kingdom (U.K.).24, 25

Although legal and ethical requirements for human subject research technically do not exclude military entities, statutory and judicial “loopholes” have emerged in the U.S.,26 while the U.K. has been slow to develop binding legal safeguards for non-military, much less military, research subjects27. As recently demonstrated by the joint U.S.-U.K. support for an invasion of Iraq,28 these two countries are strong Allies. Their respective domestic laws and policies,29 as well as international treaties,30 call for collaboration in major military matters ranging from scientific R&D to the interoperability of forces.

However, collaboration presents controversy in the context of biotechnology. Concerning biotech R&D, which inherently involves techniques such as stem cell research31 and somatic cell nuclear transfer,32 questions arise as to how the U.S., with its limit of federal funding to only existing stem cell lines33 and potential for banning any funding of therapeutic cloning,34 can effectively collaborate with the U.K., which already funds these techniques35. Considering the extent of federal funding allotted to military research36 in light of the collaboration required by both domestic and international instruments,37 compliance with the proposed U.S. restrictions becomes, at best, illusory.

Moreover, joint operability of U.S. and U.K. forces presumably requires the use of jointly operable equipment and supplies, including biotech products. Even if these products go through testing and development in the more “liberal” U.K., they would, in practice, be used on both British and American soldiers38. Oftentimes, military matters demand the use of any product that could provide even a potential advantage over the adversary, regardless of whether the product has been fully tested.39 Possible side effects of usage, especially long-term, are of little consequence in the face of a present and pressing enemy.40

Beyond research, development, and use issues surrounding biotechnology in the military are related and equally complex privacy issues invoked by, for example, the collection and storage of DNA samples from individual service members41. Although knowledge of each soldiers’ genetic make-up may be relevant, if not crucial, to present mission success,42 that same knowledge could later prove disastrous for the individual service member if revealed outside the military context43. Allied collaboration efforts further hamper confidentiality by allowing not only a service member’s own country, but potentially many foreign nations, access to the most detailed information, health-related and other, regarding individual service members.

Despite the legal and ethical concerns raised, biotechnology has, and will continue, to offer countless opportunities for enhancing military capabilities. As such, the research, development and utilization of biotech products are present realities in the U.S. and abroad, both within and outside of the defense context. However, testing and usage, as well as effective collaboration between Allies, calls for the resolution of complex and pressing issues presented by this intersection of science, technology, and human lives. Resolutions must take into account the history of abuses in military research, existing domestic and international legal and ethical safeguards, and a special respect for those serving to protect their country. In the present global “war on terrorism,”44 the U.S. and its Allies should heed this caution:

The military enterprise is at once ethical and unethical. Ethical from “our” point of view because the nation is protected from aggressors, defended when attacked, determined to win at all costs. Unethical, especially as seen through the adversary’s eyes, because anything goes. The victimization of noncombatants, misinformation and disinformation, clever feints, deception and other ploys of elaborate trickery, are the stock-in-trade of the “other” side. “We”, of course, resort to the same (and often more) to preserve the power position, strategic balance, operational gain, or tactical advantage. Might makes right, in other words, and hopefully for our team, righter yet. Not only does anything go; everything goes. The ‘un-morality’ of war rubs off on, and too often guides, those charged with researching and developing new and more effective weapons systems.45

[FOOTNOTES 20-21]

20 E.g., IATAC REPORT, supra note 11, at 89-99 app. C, 101-111 app. D (including, but not limited to, the following Exemplars: Advanced Military Medicine, including advanced vaccines and immune enhancements for expeditionary warfare and homeland security, accelerated wound healing, and stasis for critical warfighter casualties; Human Performance Enhancement, including 24x7 operations, enhanced environmental endurance for the warfighter, and enhanced cognition for improved warfighter performance). The Report also contains legal position papers favorable to the following uses of biotechnology by DoD: genetic screening for missions selection; transitory genome altering enhancements; permanent genome altering enhancements. Id. at 73-88 app. B. See also NRC REPORT, supra note 12, at 2 tbl. ES-1 (containing the following “Prospective Army Applications” [of biotech products] and their respective descriptions:

Camouflage and concealment - Biomaterials with stealth characteristics; nonilluminating paints and coatings.

Combat identification – Biological markers to distinguish friendly soldiers.

…

Functional foods – Additives to improved nutrition, enhance digestion, improved storage characteristics, enable battlefield identification, reduce detectability; edible vaccines; . . .

Health monitoring – Devices to provide feedback on soldier status, enable remote triage, and augment network of external sensors to provide intelligence on chemical, biological, or environmental agents.

. . .

Lightweight armor – Protection for soldiers and combat systems; systems with living characteristics, such as self-repairing body armor.

Novel materials – Biologically inspired materials; . . . ; genetically engineered proteins; . . .

Performance enhancement – Cortical implants; computer input and display interfaces; prostheses control; sensory enhancement; antidotal implants; gene-expression monitoring; performanceenhancing drugs.

. . .

Sensing battlefield environments – Laboratories-on-a-chip to detect and identify chemical, biological, and environmental threat molecules on the battlefield; coupling of diagnostic and therapeutic functions.

. . .

Soldier therapeutics – Drugs to counteract shock; genomics-based, directed therapies; optimized responsiveness to vaccines.

. . .

Vaccine development – Reduced development and production times for small-scale requirements to respond to disease encountered in exotic locales. Wound healing – Engineered skin, tissue, and organs; wound dressings and treatments to curtail bleeding and accelerate healing.).

21 Dr. Steve Nicklin, Medical Issues: The Future Impact of Biotechnology on Human Factors, in NATO RESEARCH & TECH. ORG., RTO MEETING PROCEEDINGS 77: HUMAN FACTORS IN THE 21ST CENTURY, RTO-MP-077 AC/323(HFM-062)TP/38 19-1 (June 11-13, 2001) (pub’d May 2002), http://www.rta.nato.int/Abstracts.asp?RestrictPanel=HFM.

Sign in to recut, update, or save this card.